Compliance

  • January 08, 2026

    Wolfspeed Securities Class Action Sent To NC Federal Court

    A securities class action case against chipmaker Wolfspeed Inc. was transferred to North Carolina federal court Wednesday following a New York judge's order directing the movement of the consolidated investor suits over alleged misrepresentations about the company's financial projections.

  • January 08, 2026

    Courts Back Agencies Despite Loper Bright Ruling, DOJ Says

    Appellate courts have mostly upheld federal agencies' interpretation of ambiguous statutes, including tax disputes, even after the U.S. Supreme Court's 2024 landmark decision that limited agency deference, a U.S. Department of Justice attorney said Thursday.

  • January 08, 2026

    5th Circ. Pushes TSA On $48M Refund Fine Against Southwest

    A Fifth Circuit judge laughed aloud at the Transportation Security Administration's statement that it lacks the capacity to refund a security service fee to millions of passengers, questioning Thursday why Southwest Airlines Co. should get dinged with a $48 million fine for failing to refund the fee to some passengers.

  • January 08, 2026

    Satellite Co. Pays $175K To End FCC's Team Telecom Case

    The Federal Communications Commission has agreed in return for a $175,000 payment to end its probe into whether a Luxembourg satellite company violated a national security deal with the U.S. government.

  • January 08, 2026

    SEC Defeats Post-Jarkesy Challenge To Industry Bans

    A U.S. Supreme Court decision curtailing the U.S. Securities and Exchange Commission's use of its administrative courts does not eliminate the agency's ability to pursue industry bans through in-house proceedings, a D.C. federal judge ruled Thursday.

  • January 08, 2026

    Wyoming's First-Of-Its-Kind Stablecoin Up For Purchase

    The public can now purchase Wyoming's state-issued stablecoin through crypto exchange Kraken, a first for a public entity, the state's stablecoin project announced Thursday.

  • January 08, 2026

    Texas AG Says P&G Is Updating Kid Fluoride Crest Label

    The Texas attorney general said Wednesday that Procter & Gamble has agreed to place information about the recommended amount of fluoride toothpaste for children on its packaging in order to show the accurate amount on its Crest toothpaste for children.

  • January 08, 2026

    Fed Eyeing Carveouts For Confidentiality Label, Bowman Says

    The Federal Reserve's top bank regulator signaled openness to easing restrictions around so-called confidential supervisory information, or CSI, saying the label has grown so broad that it can obstruct collaboration and reduce regulatory accountability.

  • January 08, 2026

    Trader Gets Win On Subpoena Ahead Of Quant Secrets Trial

    A Manhattan federal judge said Thursday that a California quantitative trader accused of stealing billion-dollar secrets from Headlands Technologies has issued an enforceable subpoena to the firm ahead of his July criminal trial and vowed to detail what information must be provided.

  • January 08, 2026

    4 Executive Pay Trends Attorneys Will Be Watching In 2026

    A potentially sweeping overhaul simplifying the U.S. Securities and Exchange Commission's disclosure regime for public company executive compensation will be top of mind for executive pay practitioners as they look for new developments in the coming year. Here's a look at this and three other areas they'll be keeping an eye on.

  • January 08, 2026

    Ex-UnitedHealth GC Joins WilmerHale As Partner In London

    After more than 25 years as a general counsel handling some of the direst corporate crises imaginable, former UnitedHealth Group general counsel Rupert Bondy is returning to London to co-lead WilmerHale's crisis management and strategic response group.

  • January 08, 2026

    EPA's Water Rule Dispute Paused Amid Legal Uncertainty

    A North Dakota federal judge is holding in abeyance seven states' challenge to a U.S. Environmental Protection Agency's rule revision that considers tribal rights in addressing water quality standards until the agency determines if it wants to defend the final law or start a new rulemaking process.

  • January 08, 2026

    Opendoor Investors Get Final OK For $39M Deal, Atty Fees

    An Arizona federal judge has granted final approval of a $39 million settlement between real estate firm Opendoor Technologies Inc. and its shareholders to resolve their claims that the company overhyped its pricing algorithm software, closing out the litigation that began in 2022.

  • January 08, 2026

    Sen. Ag Committee To Hold Crypto Markup Next Week

    The Senate Agriculture Committee intends to hold its own markup of a bill to regulate crypto markets the same day as its Banking Committee counterparts, a spokesperson confirmed Thursday.

  • January 08, 2026

    Trump Admin Says Climate Grant Class Suit Is Moot

    The Trump administration has told the D.C. Circuit that a proposed class action accusing it of illegally terminating a $3 billion environmental justice block grant program is moot because Congress has rescinded the funds that green groups and local governments are seeking to recover.

  • January 08, 2026

    Vape Companies Say ALJ Was Wrongly Appointed

    Vaping product companies NJOY LLC and Altria Group Inc. asked a Virginia federal judge to grant them a win in a suit brought against the U.S. International Trade Commission, saying an administrative law judge was improperly appointed in proceedings seeking to prevent them from importing certain e-vapor products and devices.

  • January 08, 2026

    Audits Get Final Word On Economic Substance, IRS Atty Says

    IRS attorneys provide legal guidance during audits on whether a transaction lacks economic substance, but examiners make the ultimate determination, an agency associate chief counsel said Thursday while explaining how the agency applies a powerful anti-abuse tool in audits.

  • January 08, 2026

    Trump Admin Can't Undo Block On Drug Rebate Program

    A First Circuit panel has refused to lift a district judge's block on a Trump administration plan to pilot a rebate model for a federal drug discount program that benefits low-income patients, saying the federal government is unlikely to win its appeal.

  • January 08, 2026

    Legal Services Atty Named Top NYC Human Rights Enforcer

    New York Mayor Zohran Mamdani has tapped a lawyer from a group that provides free legal services to low-income clients to spearhead the city's human rights enforcement body.

  • January 08, 2026

    IRS Floats Changes To Third-Party Settlement Payments

    The Internal Revenue Service floated changes Thursday to withholding rules for organizations such as PayPal and Venmo that make payments to settle third-party network transactions, saying the move would align regulations with an increase to the threshold for tax reporting.

  • January 08, 2026

    Calif. Agency Secures Halt On Data Broker's Info Resales

    A marketing firm that compiles and redistributes lists of people with serious health conditions has agreed to pay a $45,000 fine and stop selling California residents' personal information in order to settle the California Privacy Protection Agency's latest enforcement strike against a data broker for failing to register, the agency announced Thursday. 

  • January 08, 2026

    Paul Hastings Hires Shenkman Capital CLO As NY Partner

    Shenkman Capital Management's chief legal and compliance officer has returned to BigLaw as an investment funds and private capital partner at Paul Hastings LLP, the firm announced Thursday.

  • January 07, 2026

    Trump Bars 'Underperforming' Defense Contractors' Buybacks

    President Donald Trump said Wednesday that defense contractors are barred from buying back their own stocks or paying shareholder dividends if they are underperforming on their U.S. government contracts, ordering a review and potential "remediation plan" for contractors found slacking.

  • January 07, 2026

    10th Circ. Halts Kan. Bank's $20M FDIC Appeal For Settlement

    The Tenth Circuit will hold off on hearing a small Kansas bank's push to challenge a $20 million anti-money laundering enforcement proceeding from the Federal Deposit Insurance Corp. after the two sides said Wednesday that they have reached a settlement.

  • January 07, 2026

    House Talks Market Share Regarding Netflix-WB Merger

    Rapid consolidation in the streaming market was on the minds of members of the House Judiciary Committee's subcommittee on antitrust when they met Wednesday, with Democrats questioning if competition was being threatened and if the president was exerting too much influence on merger reviews.

Expert Analysis

  • Key Strategies For Supplement Cos. Facing Lead Risks

    Author Photo

    In the wake of a recent Consumer Reports article detailing dangerously high levels of lead in many popular protein powders, supplement companies face increased litigation, rising enforcement risks and reputational harm — underscoring the need to monitor supply chains, test ingredients and understand labeling standards, say attorneys at Husch Blackwell.

  • How AI Tech Suppliers Can Address IP Lawyers' Concerns

    Author Photo

    While artificial intelligence tools can help intellectual property lawyers be more productive and effective, AI tech providers must address issues of privilege, data privacy and confidentiality to make their technology viable and useful for IP law, say Tom Colson at Colson Law and Kevin Bronson at Simpson & Simpson.

  • From Bank Loans To Private Credit: Tips For Making The Shift

    Author Photo

    The relationship between private credit and syndicated bank deals will evolve as the private market continues to grow, introducing new challenges for borrowers comparing financing options, particularly pertaining to loan documentation and working capital, say attorneys at Haynes Boone.

  • 3 Takeaways From FDA Cell And Gene Therapy Draft Guidance

    Author Photo

    The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.

  • Wells Process Reforms Serve SEC Chair's Transparency Goals

    Author Photo

    Enforcement policy changes U.S. Securities and Exchange Commission Chairman Paul Atkins recently set forth will help fulfill his stated goal of making Division of Enforcement investigations more fair and transparent by changing the Wells process to provide recipients earlier consultations with SEC staff, greater evidence access and more time to file responses, say attorneys at Dechert.

  • The Ins And Outs Of Decentralized Digital Asset Exchanges

    Author Photo

    As decentralized digital asset exchanges lack intermediaries, and so remain susceptible to fraud and market manipulation, ​​​​​​​an understanding of their design is crucial to help market participants avoid fraudulent practices such as liquidity rug pulls, says Swati Kanoria at Charles River.

  • Contradictory Rulings Show Complexity Of Swaps Regulation

    Author Photo

    Recent divergent rulings, including two by the same Nevada judge, on whether the Commodity Exchange Act preempts state gambling laws when applied to event contracts traded on U.S. Commodity Futures Trading Commission-regulated markets illustrate the uncertainty regarding the legality of prediction markets, say attorneys at Akin.

  • How New Law Transforms Large-Load Power Projects In Texas

    Author Photo

    S.B. 6 — the new Texas law that revises state regulations for large electrical loads and related behind-the-meter projects — introduces higher up-front costs for developers and more flexible operating models for large-load customers, but should provide the certainty needed for greater investment in generation, say attorneys at Sidley.

  • How Cos. Should Prepare For Prop 65 Listing Of Bisphenols

    Author Photo

    California regulators are moving toward classifying all p,p'-bisphenol chemicals as causing reproductive toxicity under Proposition 65, which could require warning notices for a vast range of consumer and industrial products, and open the floodgates to private litigation — so companies should proactively review their suppy chains, says Gregory Berlin at Alston & Bird.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • When Mortgage Data Can't Prove Discriminatory Lending

    Author Photo

    As plaintiffs continue to use Home Mortgage Disclosure Act data as grounds for class actions, attorneys must consider the limits of a statistics-only approach and the need for manual loan file review to confirm indications of potential discriminatory lending, say Abe Chernin, Shane Oka and Kevin Oswald at Cornerstone Research.

  • NLRB Memo Shifts Tone On Defenses Against Union 'Salting'

    Author Photo

    The current Starbucks strike demonstrates the potential effects of salting, in which applicants seek employment in order to organize a union, and recent guidance from the National Labor Relations Board suggests that previously rejected employer defenses may now gain traction, says Daniel Johns at Cozen O'Connor.

  • Evaluating Nasdaq Tokenization Rule's Potential Impact

    Author Photo

    Nasdaq's recently proposed rule would enable settlement of tokenized equity securities and exchange-traded products using blockchain technology, which could lead to dramatic improvements in market efficiency, settlement speed and market access, but prudent skepticism about timelines and implementation capabilities is warranted, says James Brady at Katten.

  • FDA Biosimilar Guidance Should Ease Biologics Development

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Compliance archive.